Balyasny Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $124K | Buy |
|
|||||
|
2018
Q1 | $134K | Buy |
|
|||||
|
2017
Q4 | $148K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $16K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $1.01M | Sell |
|
|||||
|
2016
Q3 | $6.19M | Buy |
|
|||||
|
2016
Q2 | $179K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $14.9M | Buy |
|
|||||
|
2015
Q1 | $12M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $5.58M | Buy |
|
|||||
|
2014
Q1 | $1.61M | Sell |
|
|||||
|
2013
Q4 | $5.74M | Buy |
|